Profiling indomethacin impurities using high-performance liquid chromatography and nuclear magnetic resonance
- 22 October 2001
- journal article
- research article
- Published by Elsevier BV in European Journal of Pharmaceutical Sciences
- Vol. 14 (4), 301-311
- https://doi.org/10.1016/s0928-0987(01)00198-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Rapid and sensitive LC separation of new impurities in trimethoprimJournal of Pharmaceutical and Biomedical Analysis, 2001
- Quantitative analysis of N-acetylcysteine and its pharmacopeial impurities in a pharmaceutical formulation by liquid chromatography–UV detection–mass spectrometryJournal of Chromatography A, 2000
- Micellar electrokinetic and high-performance liquid chromatographic determination of potential manufacturing impurities in pholcodineJournal of Chromatography A, 2000
- Isolation and Identification of Three Potential Impurities of Pholcodine Bulk Drug SubstanceJournal of Pharmacy and Pharmacology, 2000
- Isolation and identification of process impurities in trimethoprim drug substance by high-performance liquid chromatography, atmospheric pressure chemical ionization liquid chromatography/mass spectrometry and nuclear magnetic resonance spectroscopyJournal of Pharmaceutical and Biomedical Analysis, 1999
- Simple, rapid and sensitive method for the determination of indomethacin in plasma by high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Simultaneous determinaton of indomethacin and its metabolites in rabbit plasma by high-pressure liquid chromatographyInternational Journal of Pharmaceutics, 1981
- 1-Acyl-indoles. II. A New Syntheses of 1-(p-chlorobenzoyl)-5-methoxy-3-indolylacetic Acid and Its PolymorphismCHEMICAL & PHARMACEUTICAL BULLETIN, 1968
- Non-Steroid Anti-Inflammatory AgentsJournal of the American Chemical Society, 1963
- The Seventh British PharmacopoeiaBMJ, 1948